More than 530 million people worldwide living with diabetes are at risk for developing diabetic retinal disease (DRD), the ...

Systems announced that Boehringer Ingelheim is the latest global top 20 biopharma company to commit to moving to Veeva Vault CRM.

Top biopharma company selects the next generation of CRM for life sciences as its commercial foundation for future expansion and launches BARCELONA, Spain, Nov. 14, 2024 /PRNewswire/ -- Veeva Systems ...

The $66 million project is part of the company's obligation made to the state after it moved here to invest a total of $120 ...

More than 530 million people worldwide living with diabetes are at risk for developing diabetic retinal disease (DRD), the leading cause of blindness in working-age adults. 1·DRD is a growing epidemic ...

Boehringer Ingelheim and MTM Vision join forces to combat vision loss from diabetes: Ingelheim, Germany Wednesday, November 13, 2024, 10:00 Hrs [IST] Boehringer Ingelheim and the ...

Abdulla also aims to further strengthen relationships with regional governments and key healthcare stakeholders to ensure ...

Spending the day facing the challenges of kidney patients helps workers at a CT pharmaceutical company understand disease and ...

THE German-Philippine Chamber of Commerce and Industry, Inc. (GPCCI) said preventive measures are urgently needed to address avian influenza (AI), which it called a threat to food security in the ...

Nov. 13, 2024 /PRNewswire/ — TileDB, the database designed for scientific discovery, announced today it is now utilized by 50% of the top 20 global pharmaceutical companies, including industry giant ...

Substantial enrollment progress in Phase 1b trial of SZN-043 in severe alcohol-associated hepatitis patients with proof-of-concept data expected ...